GALT
Galectin Therapeutics Inc.
NASDAQ · USHealthcareBiotechnology
$4.00-4.19%
Price as of Jul 20, 2026
GALT ownership
Galectin Therapeutics Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
7
Net (3m)
-$511.6K
Insider trades by month Buys Sells
Dec
Jan
Feb
May
Jun
Jul
Context3-month price +73.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 16, 2026 | Jamil Khurramofficer: Chief Medical Officer | Sell | 16,250 | $5.13 |
| Jul 16, 2026 | Jamil Khurramofficer: Chief Medical Officer | Option | 16,250 | $3.04 |
| Jun 30, 2026 | Shlevin Harold H.director | Option | 22,268 | $1.23 |
| Jun 30, 2026 | Shlevin Harold H.director | Sell | 22,268 | $5.04 |
| Jun 30, 2026 | Jamil Khurramofficer: Chief Medical Officer | Option | 2,037 | $2.20 |
| Jun 30, 2026 | Jamil Khurramofficer: Chief Medical Officer | Option | 47,467 | $2.50 |
| Jun 30, 2026 | Jamil Khurramofficer: Chief Medical Officer | Option | 2,533 | $2.50 |
| Jun 30, 2026 | Jamil Khurramofficer: Chief Medical Officer | Sell | 2,533 | $5.00 |
| Jun 30, 2026 | Shlevin Harold H.director | Sell | 7,732 | $5.00 |
| Jun 30, 2026 | Shlevin Harold H.director | Option | 7,732 | $1.23 |
| Jun 30, 2026 | Jamil Khurramofficer: Chief Medical Officer | Sell | 47,467 | $5.04 |
| Jun 25, 2026 | Jamil Khurramofficer: Chief Medical Officer | Sell | 7,557 | $3.14 |
| Jun 25, 2026 | Jamil Khurramofficer: Chief Medical Officer | Option | 7,557 | $1.23 |
| May 28, 2026 | Jamil Khurramofficer: Chief Medical Officer | Sell | 568 | $3.10 |
| May 28, 2026 | Jamil Khurramofficer: Chief Medical Officer | Option | 568 | $1.23 |
| Feb 9, 2026 | ELDRED KARYdirector | Buy | 300 | $2.70 |
| Jan 22, 2026 | LEWIS JOELdirector, officer: President and CEO | Grant | 91,000 | $3.04 |
| Jan 21, 2026 | AMELIO GILBERT Fdirector | Grant | 60,000 | $3.04 |
| Jan 21, 2026 | FREEMAN KEVIN Ddirector | Grant | 60,000 | $3.04 |
| Jan 21, 2026 | OMENN GILBERT Sdirector | Grant | 60,000 | — |
| Jan 21, 2026 | Shlevin Harold H.director | Grant | 60,000 | $3.04 |
| Jan 21, 2026 | CALLICUTT JACK Wofficer: Chief Financial Officer | Grant | 65,000 | $3.04 |
| Jan 21, 2026 | Jamil Khurramofficer: Chief Medical Officer | Grant | 65,000 | $3.04 |
| Jan 21, 2026 | CALLICUTT JACK Wofficer: Chief Financial Officer | Grant | 100,000 | — |
| Jan 21, 2026 | Jamil Khurramofficer: Chief Medical Officer | Grant | 100,000 | — |
| Jan 21, 2026 | CARSON BENJAMIN SRdirector | Grant | 60,000 | $3.04 |
| Jan 21, 2026 | LEWIS JOELdirector, officer: President and CEO | Grant | 84,000 | $3.04 |
| Jan 21, 2026 | LEWIS JOELdirector, officer: President and CEO | Grant | 120,000 | — |
| Jan 21, 2026 | ELDRED KARYdirector | Grant | 60,000 | $3.04 |
| Jan 21, 2026 | Uihlein Richard Edirector, 10 percent owner: | Grant | 60,000 | $3.04 |
Source: GALT SEC Form 4 filings, latest Jul 16, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their GALT positions over the last 6 months (SEC Form 13F).
Increased
66
New positions
39
Reduced
47
Sold out
24
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD GROUP INC | Increased | 2.3M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2.0M | May 15, 2026 |
| MARSHALL WACE, LLP | Increased | 1.2M | May 15, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Increased | 1.1M | May 15, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Reduced | 1.1M | Feb 17, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 1.1M | May 15, 2026 |
| GREAT POINT PARTNERS LLC | New Position | 800K | May 15, 2026 |
| BLACKROCK, INC. | Increased | 799K | May 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 798K | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 797K | Feb 12, 2026 |
| WEALTHSPIRE ADVISORS, LLC | Increased | 722K | May 1, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 613K | May 15, 2026 |
| MARSHALL WACE, LLP | Increased | 602K | Feb 13, 2026 |
| WEALTHSPIRE ADVISORS, LLC | Increased | 602K | Feb 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 598K | Feb 9, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.